is trulicity a glp 1 drug Lawsuit - July 2026 Update Trulicity Lawsuit [2026] | Stomach

There may be difficulties in having to refrigerate the injectable versions

GLP-1 based therapies: clinical implications for gastroenterologists

Summary: Pancreatitis is a rare potential side effect of GLP-1 agonists, though large clinical trials show no definitive causal link and the absolute risk remains low

By Sabina Paglialunga, PhD & Aernout van Haarst, PhD Senior Directors Scientific Affairs Glucagon-Like Peptide-1 (GLP-1) receptor agonists first came to the market in 2005 as a type 2 diabetes mellitus treatment, and they have been making headlines again for their weight reduction effects

GLP-1 has been reported to promote the production of anti-inflammatory cytokines in various organs including the adipose tissue and pancreas, and the brain (Lee et al., 2012